Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

X5 Retail Group buys Pokupochka retail chain

4/11/23 FIVE

Raspadskaya reported for 3 months of 2023 according to RAS

4/11/23 RASP

Abrau-Durso plans to expand sales of cosmetics

4/11/23 ABRD

Abrau-Durso will start vodka production

4/11/23 ABRD

Abrau-Durso dividends will increase by 32% this year

4/11/23 ABRD

Abrau-Durso" summed up the results of 2022

4/11/23 ABRD

Yuzhuralnickel reported for 3 months of 2023 according to RAS

4/11/23 UNKL

Whoosh launches electric bike rentals in St. Petersburg and the Moscow region

4/11/23 WUSH

Aeroflot's passenger traffic increased by 11.3% in Q1

4/11/23 AFLT

IDGC of Urals reported for 2022 according to IFRS

4/11/23 MRKU